摘要 |
The disclosure provides drug combinations and methods for treating human bladder cancer. The drug combination may include mitomycin, or an analogue thereof, cisplatin or an alternative platinum drug, and epirubicin or an alternative anthracycline drug and does not include gemcitabine. |